Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2004-4-5
pubmed:abstractText
Mast cells play a central role in immediate type hypersensitivity and inflammatory events. Activation of mast cells not only can result in the release of preformed granule-associated mediators generally followed by de novo synthesis of lipid-derived substances. In the present study, we show that mast cell can be activated to release lipid mediators in absence of granule exocytosis. Primary cultured murine mast cells were stimulated with substance P and produced leukotriene C4, and prostaglandin D2 without the release of the granule-associated enzyme beta-hexosaminidase. Indomethacin and nordihydroguaiaretic acid caused complete inhibition of arachidonic metabolite generation. Leukotriene C4 and prostaglandin D2 production was blocked by genistein, a specific inhibitor of tyrosine kinases, and bisindolylmaleimide, a protein kinase C inhibitor, indicating a role for both phosphorylation pathways in the substance P-stimulated lipid mediator production. We suggest that the cytokine microenvironment of the mast cell determines whether mast cell stimulation leads to only lipid mediator release or full activation. Analysis of granule-associated mediators only might underestimate the role of mast cell activation under (patho)physiological conditions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cross-Linking Reagents, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Genistein, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin E, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin, http://linkedlifedata.com/resource/pubmed/chemical/Leukotriene C4, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Maleimides, http://linkedlifedata.com/resource/pubmed/chemical/Nordihydroguaiaretic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin D2, http://linkedlifedata.com/resource/pubmed/chemical/Substance P, http://linkedlifedata.com/resource/pubmed/chemical/bisindolylmaleimide
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0014-2999
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
489
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
49-54
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15063154-Animals, pubmed-meshheading:15063154-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:15063154-Bone Marrow Cells, pubmed-meshheading:15063154-Cross-Linking Reagents, pubmed-meshheading:15063154-Cyclooxygenase Inhibitors, pubmed-meshheading:15063154-Cytoplasmic Granules, pubmed-meshheading:15063154-Enzyme Inhibitors, pubmed-meshheading:15063154-Exocytosis, pubmed-meshheading:15063154-Genistein, pubmed-meshheading:15063154-Immunoglobulin E, pubmed-meshheading:15063154-Indoles, pubmed-meshheading:15063154-Indomethacin, pubmed-meshheading:15063154-Inflammation, pubmed-meshheading:15063154-Leukotriene C4, pubmed-meshheading:15063154-Lipids, pubmed-meshheading:15063154-Maleimides, pubmed-meshheading:15063154-Mast Cells, pubmed-meshheading:15063154-Mice, pubmed-meshheading:15063154-Mice, Inbred BALB C, pubmed-meshheading:15063154-Nordihydroguaiaretic Acid, pubmed-meshheading:15063154-Prostaglandin D2, pubmed-meshheading:15063154-Signal Transduction, pubmed-meshheading:15063154-Stimulation, Chemical, pubmed-meshheading:15063154-Substance P
pubmed:year
2004
pubmed:articleTitle
Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells.
pubmed:affiliation
Department of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Sorbonnelaan 16, P.O. Box 80.082, 3508 TB Utrecht, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't